{
    "nct_id": "NCT05886491",
    "official_title": "A Phase 1/2a, Open-Label, Dose Escalation, and Dose Expansion Study to Assess the Safety and Efficacy of GDX012 in Patients With Relapsed or Refractory Acute Myeloid Leukemia",
    "inclusion_criteria": "Inclusion criteria:\n\n1. Total body weight of ≥40 kg.\n2. Must have pathologically confirmed relapsed or refractory acute myeloid leukemia (R/R AML) including:\n\n   1. Relapsed AML is defined as ≥5% blasts in the bone marrow (BM) or peripheral blood at any time after achieving a CR, CRh, Cri, or MLFS.\n   2. Refractory AML is defined as failure to achieve a CR, CRh, Cri, or MLFS after 1 of the following regimens:\n\n   i. Two courses of intensive induction chemotherapy. ii. At least 2 cycles of hypomethylating agent (HMA) or low-dose, cytarabine-based combination regimen.\n\n   iii. At least 4 cycles of HMA monotherapy.\n3. During dose escalation, participants must be ineligible for hematopoietic stem cell transplantation (HSCT).\n4. Must have an anticipated life expectancy of >3 months before lymphodepletion.\n5. Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1.\n6. Participants must have adequate renal, cardiac, hepatic, pulmonary and bone marrow function as defined by the protocol.\n\nExclusion criteria:\n\n1. Diagnosis of acute promyelocytic leukemia.\n2. Has received or plans to receive any of the excluded therapy/treatment within the specified timeframe before lymphodepleting chemotherapy as defined by the protocol.\n3. Prior allogeneic HSCT within 3 months of signing informed consent form (ICF) or with ongoing requirement for systemic graft-versus-host therapy.\n4. Active central nervous system (CNS) involvement.\n5. History of malignancy other than non-melanoma skin cancer or carcinoma in situ (eg. cervix, bladder, breast) low grade prostate cancer without treatment requirement unless in remission without treatment for ≥2 years.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}